Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 18, 2022 Filed Jan 21, 2022 00:24 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionCommon Stock 6,338 $43.54 $275,956.52
Disclosure

SEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 3

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:24 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionCommon Stock 2,600 $38.35 $99,710.00
Disclosure

SEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 2

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:24 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionCommon Stock 1,375 $44.20 $60,775.00
Disclosure

SEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:21 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 224 $63.55 $14,235.20
Disclosure

SEC source: 0001209191-22-004198 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,550

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:22 UTC
RIKER LAURENSenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-22-004200 · doc4.xml · derivative · entry 3

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,300

Underlying: Common Stock · 2,500 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:22 UTC
RIKER LAURENSenior Vice President, Finance
SaleCommon Stock 2,500 $64.97 $162,430.00
Disclosure

SEC source: 0001209191-22-004200 · doc4.xml · nonDerivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,152

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 00:22 UTC
RIKER LAURENSenior Vice President, Finance
Exercise / conversionCommon Stock 2,500 $10.81 $27,025.00
Disclosure

SEC source: 0001209191-22-004200 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 11, 2022 Filed Jan 13, 2022 16:11 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-22-003176 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,670

Underlying: Common Stock · 15,000 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
January 11, 2022 Filed Jan 13, 2022 16:11 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 15,000 $10.81 $162,150.00
Disclosure

SEC source: 0001209191-22-003176 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 289 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021.

Read SEC document
January 04, 2022 Filed Jan 10, 2022 22:32 UTC
RIKER LAURENSenior Vice President, Finance
GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $61.60 $0.00
Disclosure

SEC source: 0001209191-22-002726 · doc4.xml · derivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-04

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on December 7, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
January 04, 2022 Filed Jan 10, 2022 22:32 UTC
RIKER LAURENSenior Vice President, Finance
GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-002726 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,152

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
January 04, 2022 Filed Jan 10, 2022 22:28 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $61.60 $0.00
Disclosure

SEC source: 0001209191-22-002725 · doc4.xml · derivative · entry 2

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-04

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on December 7, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
January 04, 2022 Filed Jan 10, 2022 22:28 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-002725 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,774

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

F2 · balance_after: Includes 224 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021.

Read SEC document
December 17, 2021 Filed Dec 20, 2021 16:13 UTC GiftCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-070553 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,908

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:25 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001209191-21-066795 · doc4.xml · derivative · entry 2

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2027-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:25 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
Exercise / conversionCommon Stock 7,500 $44.10 $330,750.00
Disclosure

SEC source: 0001209191-21-066795 · doc4.xml · nonDerivative · entry 1

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

Read SEC document
November 16, 2021 Filed Nov 18, 2021 16:22 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-21-065463 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,670

Underlying: Common Stock · 15,000 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
November 16, 2021 Filed Nov 18, 2021 16:22 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 15,000 $10.81 $162,150.00
Disclosure

SEC source: 0001209191-21-065463 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 129 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 21:22 UTC
WINSTON ROYChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $48.15 $0.00
Disclosure

SEC source: 0001209191-21-063386 · doc4.xml · derivative · entry 2

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 21:22 UTC
WINSTON ROYChief Medical Officer
Exercise / conversionCommon Stock 10,000 $48.15 $481,500.00
Disclosure

SEC source: 0001209191-21-063386 · doc4.xml · nonDerivative · entry 1

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 20:29 UTC
SLONIN JONATHANChief Clinical Officer
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $60.79 $0.00
Disclosure

SEC source: 0001209191-21-049940 · doc4.xml · derivative · entry 2

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-07-20

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on July 20, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 20:29 UTC
SLONIN JONATHANChief Clinical Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-049940 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,350

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on August 1, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 20:33 UTC
WINSTON ROYChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $60.79 $0.00
Disclosure

SEC source: 0001209191-21-049945 · doc4.xml · derivative · entry 2

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-07-20

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on June 20, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 20:33 UTC
WINSTON ROYChief Medical Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-049945 · doc4.xml · nonDerivative · entry 1

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,456

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on August 1, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

Read SEC document
July 29, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 90 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · derivative · entry 6

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,800

Underlying: Common Stock · 90 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
July 29, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
SaleCommon Stock 90 $60.81 $5,472.90
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 4

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,152

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
July 29, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
Exercise / conversionCommon Stock 90 $10.81 $972.90
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 3

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,242

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
July 28, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,410 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · derivative · entry 5

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,890

Underlying: Common Stock · 2,410 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
July 28, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
SaleCommon Stock 2,410 $60.85 $146,648.50
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,152

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.81 to $60.858, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 28, 2021 Filed Jul 30, 2021 20:21 UTC
RIKER LAURENVice President, Finance
Exercise / conversionCommon Stock 2,410 $10.81 $26,052.10
Disclosure

SEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 22:14 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 421 $59.76 $25,158.96
Disclosure

SEC source: 0001209191-21-045622 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

Read SEC document
June 11, 2021 Filed Jun 12, 2021 00:39 UTC
RIKER LAURENVice President, Finance
SaleCommon Stock 2,003 $59.85 $119,879.55
Disclosure

SEC source: 0001209191-21-040092 · doc4.xml · nonDerivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,731

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.820 to $59.845, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote.

Read SEC document
June 10, 2021 Filed Jun 12, 2021 00:38 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 847 $60.57 $51,302.79
Disclosure

SEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 3

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,268

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.20 to $60.92, inclusive.

Read SEC document
June 10, 2021 Filed Jun 12, 2021 00:38 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 4,842 $59.43 $287,760.06
Disclosure

SEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 2

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,115

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.03 to $59.99, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:35 UTC
Manning Donald C.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040088 · doc4.xml · derivative · entry 2

Manning Donald C. · CIK 0001775268 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:35 UTC
Manning Donald C.Chief Medical Officer
GrantCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040088 · doc4.xml · nonDerivative · entry 1

Manning Donald C. · CIK 0001775268 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,520

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:32 UTC GrantStock Option (Right to Buy) · Derivative 7,626 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040082 · doc4.xml · derivative · entry 2

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626

Underlying: Common Stock · 7,626 shares

Expires 2031-06-09

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:32 UTC GrantCommon Stock 1,066 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040082 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,308

F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:40 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040093 · doc4.xml · derivative · entry 2

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:40 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040093 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,799

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:32 UTC GrantStock Option (Right to Buy) · Derivative 7,626 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040083 · doc4.xml · derivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626

Underlying: Common Stock · 7,626 shares

Expires 2031-06-09

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:32 UTC GrantCommon Stock 1,066 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040083 · doc4.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,087

F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 12, 2021 00:38 UTC
WILLIAMS KRISTENChief Administrative Officer
GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040090 · doc4.xml · derivative · entry 4

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2031-06-09

F5 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 09, 2021 Filed Jun 12, 2021 00:38 UTC
WILLIAMS KRISTENChief Administrative Officer
GrantCommon Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,957

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:35 UTC GrantStock Option (Right to Buy) · Derivative 7,626 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040087 · doc4.xml · derivative · entry 2

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626

Underlying: Common Stock · 7,626 shares

Expires 2031-06-09

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:35 UTC GrantCommon Stock 1,066 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040087 · doc4.xml · nonDerivative · entry 1

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,823

F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:38 UTC
STACK DAVID MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 133,400 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040091 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,400

Underlying: Common Stock · 133,400 shares

Expires 2031-06-09

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:38 UTC
STACK DAVID MDirector · CEO and Chairman
GrantCommon Stock 17,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040091 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,956

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 09, 2021 Filed Jun 12, 2021 00:47 UTC
PACE GARY WDirector
GrantStock Option (Right to Buy) · Derivative 7,626 $0.00 Strike: $60.96 $0.00
Disclosure

SEC source: 0001209191-21-040097 · doc4.xml · derivative · entry 3

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626

Underlying: Common Stock · 7,626 shares

Expires 2031-06-09

Read SEC document
June 09, 2021 Filed Jun 12, 2021 00:47 UTC
PACE GARY WDirector
GrantCommon Stock 1,066 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040097 · doc4.xml · nonDerivative · entry 2

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,530

F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.